Valve in Valve mitral as a management option in bioprosthetic valve dysfunction
Abstract views: 107
/ 
PDF downloads: 93
DOI:
https://doi.org/10.58372/2835-6276.1016Keywords:
Bioprosthesis, Mitral valve, DysfunctionAbstract
Introduction: Mitral valve disease is one of the most frequent valvulopathies, within the indications for management one of the options is valve replacement, however, these patients over time can develop bioprosthetic valve dysfunction, being patients considered at high surgical risk due to the previous intervention.
Methodology: A bibliographic search was carried out through pubmed using the following terms: (bioprosthetic valve dysfunction) published articles were analyzed.
Results: Articles were identified by searching pubmed for articles on Valve in Valve mitral.
Conclution: The transcatheter mitral valve is an option for high-risk patients with previous biological valve dysfunction with a high success rate and low risk of complications.
References
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 2022 Feb 12;43(7):561–632.
Otto CM, Nishimura RA,Bonow RO, Carabello BA, Erwin JP, Gentile F, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5).
Whisenant B, Kapadia SR, Eleid MF, Kodali SK, mccabe JM, Krishnaswamy A, et al. One-Year Outcomes of Mitral Valve-in-Valve Using the SAPIEN 3 Transcatheter Heart Valve. JAMA Cardiology. 2020 Nov 1;5(11):1245.
Badhwar V, Rankin JS, He X, Jacobs JP,Gammie JS, Furnary AP, et al. The Society of Thoracic Surgeons Mitral Repair/Replacement Composite Score: A Report of The Society of Thoracic Surgeons Quality Measurement Task Force. The Annals of Thoracic Surgery. 2016 Jun;101(6):2265–71.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, et al. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European Heart Journal-Cardiovascular Imaging. 2013 Jul 1;14(7):611–44.
Belluschi I, Buzzatti N, Castiglioni A, de Bonis M, Maisano F, Alfieri O. Aortic and mitral bioprosthetic valve dysfunction: surgical or percutaneous solutions? European Heart Journal Supplements. 2021 Oct 9;23(Supplement_E):E6–12.
Pirelli L, Hong E, Steffen R,Vahl TP, Kodali SK, Bapat V. Mitral valve-in-valve and valve-in- ring: tips, tricks, and outcomes. Annals of Cardiothoracic Surgery. 2021 Jan;10(1):96–112.
Zia Khan M, Zahid S, Khan MU,Kichloo A, Jamal S, Mannan Khan Minhas A, et al. Redo Surgical Mitral Valve Replacement Versus Transcatheter Mitral Valve in Valve From the National Inpatient Sample. J Am Heart Assoc. 2021 Sep 7;10(17).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 American Journal of Medical and Clinical Research & Reviews
This work is licensed under a Creative Commons Attribution 4.0 International License.
The journal is licensed under a 